Appendix 4C - June 2014 Quarterly Cash Flow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Amplia Therapeutics Ltd. on 6ix
Earlier from Amplia Therapeutics
- Appendix 4C - Dec 2015 Quarterly Cash Flow Report
- Update on Phase 2B Trial of MIS416
- Response to ASX price and volume query
- Preliminary Final Report - Year Ended 31 March 2015
- Preliminary Final Report - Year Ended 31 March 2014
Later from Amplia Therapeutics
- Appendix 4C - Dec 2013 Quarterly Cash Flow Statement
- Update on Innates Phase 2B trial and recent activities
- Clinical Trial Fully Enrolled and Strong Interest
- Appendix 4C - Statement of Cashflows March 2016 Qtr
- Preliminary Final Report - YE 31 March 2016
Follow Amplia Therapeutics into a list and get an email when it puts out news.
Follow Amplia Therapeutics